Novavax sells Czech manufacturing facility to Novo Nordisk for $200 mn

Quick Summary:

The divestiture of the Czech facility follows U.S.-based Novavax's licensing deal worth at least $1.

Don't miss the most important news and views of the day.

It had also raised doubts about its ability to stay in business in 2023.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaCzech Republic

Topics: Novavax sale Pharmaceutical industry Sanofi deal $200 million Novo nordisk Vaccine manufacturing Covid-19 vaccine John jacobs Novavax Czech facility

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-12-04 @ 14:35:49 (13 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 300 words

Reading Time: 2 minutes read

Sentences: 11 lines

Sentence Length: 28 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 24115299

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 355 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions